ADD

Andrew D. Dickinson Portfolio

Invests via GILEAD SCIENCES Inc. | Managed by Andrew D. Dickinson
Invests via GILEAD SCIENCES Inc.
Managed by Andrew D. Dickinson
Automatically Tracked
Tracking: 0 Updated: Jul 15 at 03:46 PM
Andrew D. Dickinson Profile

With a diverse background in financial services, Andrew D. Dickinson has established himself as a key figure in corporate finance and strategic development. He is known for his experience leading organizations through critical phases of growth and transformation. His tenure at various public companies has honed his skills in driving operational efficiency and market expansion initiatives, making him an influential player in the industry. Through thoughtful leadership and stakeholder engagement, he consistently leverages business acumen to foster innovation and profitability within complex organizational frameworks.

With a diverse background in financial services, Andrew D. Dickinson has established himself as a key figure in corporate finance and strategic development. He is known for his experience leading organizations through critical phases of growth and transformation. His tenure at various public companies has honed his skills in driving operational efficiency and market expansion initiatives, making him an influential player in the industry. Through thoughtful leadership and stakeholder engagement, he consistently leverages business acumen to foster innovation and profitability within complex organizational frameworks.

Investment Philosophy & Strategy
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
1.8%
Gain
Monthly
0.1%
Yearly
1.17%
Drawdown
27.5%
$2.01B
Equity
Holdings
$2.01B
Investment
$1.55B
$486.62M
Profit -$15.93M
Realized
$29.21M
Unrealized
$457.41M
Dividends
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
-$15.93M
Win %
88%
This Week
Compared To Last Week
Gain
-4.99%
Profit
-$105.66M
Win %
88%
This Month
Compared to last month
Gain
-5.07%
Profit
-$107.41M
Win %
88%
This Year
Compared to last year
Gain
-4.48%
Profit
-$95.44M
Win %
88%
Arcellx, Inc. logo
ACLX Arcellx, Inc.
0%
$0
Galapagos NV American Depositary Receipt logo
GLPG Galapagos NV American Depositary Receipt
0%
$0
Kyverna Therapeutics, Inc. logo
KYTX Kyverna Therapeutics, Inc.
-2.77%
-$907,746.18
Arcus Biosciences Inc. logo
RCUS Arcus Biosciences Inc.
-1.55%
-$13.83M
Assembly Biosciences Inc. logo
ASMB Assembly Biosciences Inc.
-0.98%
-$1.18M
Xilio Therapeutics, Inc. logo
XLO Xilio Therapeutics, Inc.
-0.33%
-$19,511.67
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
25
Longs Won
8/25 32%
Profit Factor
22.14
Profitability
Shorts Won
0/0 0%
Standard Deviation
$78.58M
Average Win
$63.71M
Best Trade
(Jul 09) $453.02M
Sharpe Ratio
-12.22
Average Loss
-$1.35M
Worst Trade
(Dec 30) -$12.88M
Z-Score
1.24 (78.43%)
Commissions
$0
Avg. Trade Length
9m 3w 6d
Expectancy
$19.46M
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% 0.02% 0.18% 1.19% 6.25% 27%
Consecutive Losing Trades 1,486 1,337 1,189 1,040 892 743 594 446 297 149
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV